B. Braun to Promote Drug Development Products at 2014 AAPS Annual Meeting and Exposition

Share Article

Company to showcase its medical device products and contract manufacturing services at pharma-focused event

B. Braun’s OEM Division will attend the 2014 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition, November 2-6, at the San Diego Convention Center in San Diego, Calif.

B. Braun’s OEM Division (Booth #1155) will promote products and packaging that pharmaceutical and biotech companies can use throughout their product life cycles from drug development through commercialization.

B. Braun products on display will include:

B. Braun’s OEM Division can provide standard products and assemblies as well as custom products and fully packaged and sterilized procedure kits for the pharmaceutical market.

The 2014 AAPS Annual Meeting and Exposition is a dynamic international forum for the exchange of knowledge among scientists to enhance their contributions to public health. The expected 9,000 attendees will include scientists working in drug design, discovery, development, delivery, packaging, scale-up, clinical trials, and regulatory sciences. The AAPS Annual Meeting will allow guests to meet their peers in all disciplines, discuss the latest research presented at Contributed Paper poster sessions, and discuss projects with current and new suppliers.

For more information, contact B. Braun’s OEM Division toll free at 866-8-BBRAUN or visit http://www.bbraunoem.com.

About B. Braun’s OEM Division
B. Braun’s OEM Division delivers complete contract manufacturing capabilities focusing on fluid administration and admixture products, kits, valves, catheters and interventional accessories. OEM takes customers’ designs from the earliest stages through design prototyping, assembly, packaging and sterilization. The OEM Division of B. Braun Medical Inc. is based in Bethlehem, Pa.

About B. Braun
B. Braun Medical Inc. (B.Braun), a leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the healthcare industry. The Company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. Guided by its “Sharing Expertise®” philosophy, B.Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs.

The B.Braun Group of Companies in the U.S. includes B.Braun, B. Braun Interventional Systems, Aesculap® and CAPS®. B.Braun’s U.S. headquarters is located in Bethlehem, Pennsylvania. The B.Braun Group of Companies employs more than 50,000 employees in 60 countries throughout the world.

To learn more about B.Braun visit http://www.BBraunUSA.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Michael Drabenstott
+1 (484) 821-0920 Ext: 704
Email >
Visit website